|
Volumn 15, Issue 5, 1999, Pages 1027-1031
|
Growth inhibition of myeloid leukemia cells by troglitazone, a ligand for peroxisome proliferator activated receptor gamma, and retinoids.
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
2,4 THIAZOLIDINEDIONE DERIVATIVE;
ALITRETINOIN;
ANTINEOPLASTIC AGENT;
ANTIOXIDANT;
CELL RECEPTOR;
CHROMAN DERIVATIVE;
DNA BINDING PROTEIN;
RETINOIC ACID;
SUPEROXIDE;
THIAZOLE DERIVATIVE;
TRANSCRIPTION FACTOR;
TROGLITAZONE;
ARTICLE;
CELL CULTURE;
CELL CYCLE;
CELL DIFFERENTIATION;
CELL DIVISION;
CELL STRAIN HL 60;
CELL STRAIN U937;
DRUG EFFECT;
HUMAN;
METABOLISM;
MYELOID LEUKEMIA;
PHYSIOLOGY;
ANTINEOPLASTIC AGENTS;
ANTIOXIDANTS;
CELL CYCLE;
CELL DIFFERENTIATION;
CELL DIVISION;
CHROMANS;
DNA-BINDING PROTEINS;
HL-60 CELLS;
HUMANS;
LEUKEMIA, MYELOID;
RECEPTORS, CYTOPLASMIC AND NUCLEAR;
SUPEROXIDES;
THIAZOLES;
THIAZOLIDINEDIONES;
TRANSCRIPTION FACTORS;
TRETINOIN;
TUMOR CELLS, CULTURED;
U937 CELLS;
MLCS;
MLOWN;
|
EID: 0033227792
PISSN: 10196439
EISSN: None
Source Type: Journal
DOI: 10.3892/ijo.15.5.1027 Document Type: Article |
Times cited : (73)
|
References (0)
|